Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety and Tolerability,”

18,683 trials

Showing 20 of 18,683 results

Early research (Phase 1)Study completedNCT01474330
What this trial is testing

A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC-4047) in Healthy Male Subjects

Who this might be right for
Healthy
Celgene 33
Testing effectiveness (Phase 2)Ended earlyNCT03215030
What this trial is testing

Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Teva Branded Pharmaceutical Products R&D LLC 272
Early research (Phase 1)Study completedNCT01057030
What this trial is testing

Multiple Dose Japanese Bridging Study

Who this might be right for
Alzheimer Disease
Bristol-Myers Squibb 22
Large-scale testing (Phase 3)Looking for participantsNCT07282665
What this trial is testing

Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

Who this might be right for
Clostridioides Difficile Associated Disease
Pfizer 32,000
Early research (Phase 1)Study completedNCT05400265
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of HLX26 and HLX10 in Patients With Advanced/Metastatic Solid Tumor

Who this might be right for
Adult Solid Tumor
Shanghai Henlius Biotech 9
Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Testing effectiveness (Phase 2)Study completedNCT01149200
What this trial is testing

Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Bowel Syndrome
Targacept Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01412151
What this trial is testing

Creatine Safety & Tolerability in Huntington's Disease

Who this might be right for
Huntington's Disease (HD)
Massachusetts General Hospital 10
Early research (Phase 1)UnknownNCT05258331
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
GC Cell Corporation 24
Early research (Phase 1)Study completedNCT05136053
What this trial is testing

A Study Investigating Lu AG22515 in Healthy Adults

Who this might be right for
Healthy Participants
H. Lundbeck A/S 58
Early research (Phase 1)Study completedNCT05378737
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Who this might be right for
Advanced Solid Tumors
Bio-Thera Solutions 216
Early research (Phase 1)Active Not RecruitingNCT05174637
What this trial is testing

FDA018-ADC in Patients With Advanced Solid Tumors

Who this might be right for
Advanced/ Metastatic Solid Tumors
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT02174237
What this trial is testing

Test the Safety/Tolerability of Increasing Doses of LNP1892 Versus Placebo in Healthy Male/Female Subjects

Who this might be right for
Healthy
Lupin Ltd. 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04980872
What this trial is testing

The Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

Who this might be right for
PIK3CA-Related Overgrowth Spectrum (PROS)/Proteus Syndrome (PS)
Merck Sharp & Dohme LLC 60
Early research (Phase 1)Not Yet RecruitingNCT07346495
What this trial is testing

Remternetug (LY3372993) in Healthy Chinese Participants

Who this might be right for
Healthy
Eli Lilly and Company 24
Testing effectiveness (Phase 2)Study completedNCT02579239
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
Limb-Girdle Muscular DystrophiesFacioscapulohumeral Muscular Dystrophy
aTyr Pharma, Inc. 18
Not applicableLooking for participantsNCT06752577
What this trial is testing

Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney DiseasesKidney Transplant
Mayo Clinic 75
Early research (Phase 1)Study completedNCT06675175
What this trial is testing

A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.

Who this might be right for
Chronic Kidney DiseaseAtherosclerotic Cardiovascular Disease
AstraZeneca 29
Testing effectiveness (Phase 2)Looking for participantsNCT06538857
What this trial is testing

CEB-01 in Locally Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma
CEBIOTEX 39
Early research (Phase 1)Study completedNCT00599612
What this trial is testing

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 6
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation